Drugs that contain Pramipexole Dihydrochloride
1. List of Mirapex Er drug patents
MIRAPEX ER's oppositions filed in EPO
MIRAPEX ER Litigations
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7695734 | BOEHRINGER INGELHEIM | Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
Apr, 2028
(4 years from now) | |
| US8679533 | BOEHRINGER INGELHEIM | Pramipexole once-daily dosage form |
Sep, 2029
(6 years from now) | |
Do you want to check out MIRAPEX ER patents from before 2022?
Market Authorisation Date: 19 February, 2010
Treatment: Treatment of parkinson's disease
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of MIRAPEX ER before it's patent expiration?
More Information on Dosage
MIRAPEX ER family patents
25
United States
16
European Union
10
Japan
9
China
8
Australia
7
EA
7
Korea, Republic of
7
Canada
7
New Zealand
6
Mexico
6
Brazil
6
South Africa
6
Taiwan
5
Denmark
5
Spain
5
Cyprus
5
Portugal
5
Poland
5
Norway
5
Hong Kong
5
Slovenia
5
Argentina
4
Ecuador
4
Croatia
4
Austria
4
ME
4
Ukraine
4
Germany
3
Israel
3
Malaysia
3
RS
2
Panama
2
Iceland
2
AP
2
OA
2
Tunisia
2
Uruguay
2
Peru
2
Costa Rica
2
Singapore
2
Morocco
2
Georgia
2
Cuba
1
Yugoslavia
1
Russia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic